CytoAurora Welcomes Mr. Jaber and Delegation to Explore CTC Innovation
News on Aug 5, 2026 CytoAurora Welcomes Mr. Jaber and Delegation to Explore CTC Innovation
Dr. Kich Aungvitulsatit, Chief Executive Officer (CEO), together with Mr. Sutee Satanasathaporn, Managing Director, and the company’s advisory board, officially welcomed Mr. Jaber Ali Ibrahim Malik Alshehhi, Head of the Economic Affairs Section of the Embassy of the United Arab Emirates (UAE) in Thailand, and his delegation.
The visit took place at CytoAurora Biotechnology (Thailand) Co., Ltd. on August 5, 2026, on the occasion of their visit to observe the company’s innovation in the detection of Circulating Tumor Cells (CTCs)—cancer cells that have entered the bloodstream.
During the visit, the company’s executive team guided the delegation through the laboratory and demonstrated the operation of the CMS 200 and CR6 systems, showcasing the technological advancements behind the research and development of this innovation.
This represents an important innovation with the potential to advance precision medicine in the future. Both parties also exchanged views on opportunities to expand economic cooperation and collaboration in healthcare innovation between the two countries.
📌 Stay updated with our news and health insights:
🟢 LINE: @cytohealthcare
🔵Facebook: CytoAurora Thailand Official
🔴 Website: https://www.cytoaurorathailand.com/